Divis Gregory J has filed 19 insider transactions across 1 company since June 2023.
Most recent transaction: a disposition of 310000 shares of AVADEL PHARMACEUTICALS PLC ($AVDL) on February 12, 2026.
Activity breakdown: 3 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 12, 2026 | AVADEL PHARMACEUTICALS PLC | $AVDL | Divis Gregory J | Chief Executive Officer | D | Stock Option (Right to Buy) | 310000 | $0.00 | 0.0000 | 101,276,000 | 100.00% | 0.31% |
| Feb. 12, 2026 | AVADEL PHARMACEUTICALS PLC | $AVDL | Divis Gregory J | Chief Executive Officer | D | Stock Option (Right to Buy) | 50000 | $0.00 | 0.0000 | 101,276,000 | 100.00% | 0.05% |
| Feb. 12, 2026 | AVADEL PHARMACEUTICALS PLC | $AVDL | Divis Gregory J | Chief Executive Officer | D | Stock Option (Right to Buy) | 100000 | $0.00 | 0.0000 | 101,276,000 | 100.00% | 0.10% |
| Feb. 12, 2026 | AVADEL PHARMACEUTICALS PLC | $AVDL | Divis Gregory J | Chief Executive Officer | D | Stock Option (Right to Buy) | 400000 | $0.00 | 0.0000 | 101,276,000 | 100.00% | 0.39% |
| Feb. 12, 2026 | AVADEL PHARMACEUTICALS PLC | $AVDL | Divis Gregory J | Chief Executive Officer | D | Stock Option (Right to Buy) | 500000 | $0.00 | 0.0000 | 101,276,000 | 100.00% | 0.49% |
| Feb. 12, 2026 | AVADEL PHARMACEUTICALS PLC | $AVDL | Divis Gregory J | Chief Executive Officer | D | Stock Option (Right to Buy) | 310000 | $0.00 | 0.0000 | 101,276,000 | 100.00% | 0.31% |
| Feb. 12, 2026 | AVADEL PHARMACEUTICALS PLC | $AVDL | Divis Gregory J | Chief Executive Officer | D | Stock Option (Right to Buy) | 350000 | $0.00 | 0.0000 | 101,276,000 | 100.00% | 0.35% |
| Feb. 12, 2026 | AVADEL PHARMACEUTICALS PLC | $AVDL | Divis Gregory J | Chief Executive Officer | D | Stock Option (Right to Buy) | 600000 | $0.00 | 0.0000 | 101,276,000 | 100.00% | 0.59% |
| Feb. 12, 2026 | AVADEL PHARMACEUTICALS PLC | $AVDL | Divis Gregory J | Chief Executive Officer | D | Ordinary Shares | 211105 | $21.00 | 0.0000 | 101,276,000 | 100.00% | 0.21% |
| Feb. 12, 2026 | AVADEL PHARMACEUTICALS PLC | $AVDL | Divis Gregory J | Chief Executive Officer | D | Ordinary Shares | 10000 | $21.00 | 0.0000 | 101,276,000 | 100.00% | 0.01% |
| Feb. 12, 2026 | AVADEL PHARMACEUTICALS PLC | $AVDL | Divis Gregory J | Chief Executive Officer | D | Stock Option (Right to Buy) | 150000 | $0.00 | 0.0000 | 101,276,000 | 100.00% | 0.15% |
| Feb. 12, 2026 | AVADEL PHARMACEUTICALS PLC | $AVDL | Divis Gregory J | Chief Executive Officer | D | Stock Option (Right to Buy) | 100000 | $0.00 | 0.0000 | 101,276,000 | 100.00% | 0.10% |
| March 5, 2025 | AVADEL PHARMACEUTICALS PLC | $AVDL | Divis Gregory J | Chief Executive Officer | A | Ordinary Shares | 52000 | $0.00 | 221,100.0000 | 95,141,000 | 30.75% | 0.05% |
| March 5, 2025 | AVADEL PHARMACEUTICALS PLC | $AVDL | Divis Gregory J | Chief Executive Officer | A | Stock Option (Right to Buy) | 310000 | $0.00 | 310,000.0000 | 95,141,000 | 9999.99% | 0.33% |
| Dec. 6, 2024 | AVADEL PHARMACEUTICALS PLC | $AVDL | Divis Gregory J | Chief Executive Officer | P | Ordinary Shares | 9598 | $9.98 | 168,698.0000 | 96,300,000 | 6.03% | 0.01% |
| Dec. 9, 2024 | AVADEL PHARMACEUTICALS PLC | $AVDL | Divis Gregory J | Chief Executive Officer | P | Ordinary Shares | 402 | $9.82 | 169,100.0000 | 96,300,000 | 0.24% | 0.00% |
| Feb. 20, 2024 | AVADEL PHARMACEUTICALS PLC | $AVDL | Divis Gregory J | Chief Executive Officer | A | Stock Option (Right to Buy) | 600000 | $0.00 | 600,000.0000 | 80,174,000 | 9999.99% | 0.75% |
| Aug. 10, 2023 | AVADEL PHARMACEUTICALS PLC | $AVDL | Divis Gregory J | Chief Executive Officer | P | ADSs | 10000 | $13.20 | 159,100.0000 | 60,094,000 | 6.71% | 0.02% |
| June 5, 2023 | AVADEL PHARMACEUTICALS PLC | $AVDL | Divis Gregory J | Chief Executive Officer | A | Stock Option (Right to Buy) | 350000 | $0.00 | 350,000.0000 | 60,094,000 | 9999.99% | 0.58% |